BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6896460)

  • 1. Progressive development of a thrombin inhibitor binding site.
    Hibbard LS; Nesheim ME; Mann KG
    Biochemistry; 1982 May; 21(10):2285-92. PubMed ID: 6896460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation of prothrombin by the prothrombinase complex. The contribution of the substrate-membrane interaction to catalysis.
    Walker RK; Krishnaswamy S
    J Biol Chem; 1994 Nov; 269(44):27441-50. PubMed ID: 7961657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
    Liu LW; Ye J; Johnson AE; Esmon CT
    J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and autolysis of human meizothrombin in the presence of dansylarginine-N-(3-ethyl-1,5-pentanediyl)amide.
    Pei G; Lentz BR
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):309-16. PubMed ID: 1893062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism.
    Krishnaswamy S; Church WR; Nesheim ME; Mann KG
    J Biol Chem; 1987 Mar; 262(7):3291-9. PubMed ID: 3818642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin.
    Stevens WK; Nesheim ME
    Biochemistry; 1993 Mar; 32(11):2787-94. PubMed ID: 8457546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen-sepharose interaction with prothrombin, prethrombin 1, prethrombin 2 and thrombin.
    Kaczmarek E; Kaminski M; McDonagh J
    Biochim Biophys Acta; 1987 Aug; 914(3):275-82. PubMed ID: 3620475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dansylarginine N-(3-ethyl-1.5-pentanediyl)amide. A potent and selective fluorescent inhibitor of butyrylcholinesterase.
    Brimijoin S; Mintz KP; Prendergast FG
    Biochem Pharmacol; 1983 Feb; 32(4):699-706. PubMed ID: 6830632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction.
    Krishnaswamy S; Mann KG; Nesheim ME
    J Biol Chem; 1986 Jul; 261(19):8977-84. PubMed ID: 3755135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of lanthanide ions for calcium ions in the activation of bovine prothrombin by activated factor X. High affinity metal-binding sites of prothrombin and the derivatives of prothrombin activation.
    Furie BC; Mann KG; Furie B
    J Biol Chem; 1976 Jun; 251(11):3235-41. PubMed ID: 931985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin exosite for fibrinogen recognition is partially accessible in prothrombin.
    Ni F; Ning Q; Jackson CM; Fenton JW
    J Biol Chem; 1993 Aug; 268(23):16899-902. PubMed ID: 8349581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid.
    Boskovic DS; Giles AR; Nesheim ME
    J Biol Chem; 1990 Jun; 265(18):10497-505. PubMed ID: 2355010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the association between prothrombin fragment 2 and alpha-thrombin.
    Myrmel KH; Lundblad RL; Mann KG
    Biochemistry; 1976 Apr; 15(8):1767-73. PubMed ID: 944591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amide H/2H exchange reveals a mechanism of thrombin activation.
    Koeppe JR; Komives EA
    Biochemistry; 2006 Jun; 45(25):7724-32. PubMed ID: 16784223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage and activation of human prothrombin by Echis carinatus venom.
    Briet E; Noyes CM; Roberts HR; Griffith MJ
    Thromb Res; 1982 Sep; 27(5):591-600. PubMed ID: 6758184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the thrombin-catalyzed feedback cleavage of fragment 1.2 at Arg154-Ser155 promotes the release of thrombin from the catalytic surface during the activation of bovine prothrombin.
    Nesheim ME; Abbott T; Jenny R; Mann KG
    J Biol Chem; 1988 Jan; 263(2):1037-44. PubMed ID: 3422076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and folding of recombinant bovine prethrombin-2 and its activation to thrombin.
    DiBella EE; Maurer MC; Scheraga HA
    J Biol Chem; 1995 Jan; 270(1):163-9. PubMed ID: 7814368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of manganese with bovine prothrombin and its thrombin-mediated cleavage products.
    Bajaj SP; Nowak T; Castellino FJ
    J Biol Chem; 1976 Oct; 251(20):6294-9. PubMed ID: 977569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.